Biodexa hits 100-patient enrollment in Phase 3 FAP trial of eRapaOct 14Clinical readoutBiodexa Pharmaceuticals Plc
Rocket Pharmaceuticals says FDA aligns on Danon disease pivotal trial pathSep 15Clinical readoutRocket Pharmaceuticals, Inc.
Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruitingAug 21Weekly roundup, 8 itemsGIA632inclisiran